Visit https://www.peervoice.com/QGT860 to view the entire programme with slides. After completing “Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAs”, participants will be able to: Discuss the burden of stroke in patients with type 2 diabetes mellitus (T2DM) and recognise features of stroke in patients at risk; Analyse the safety and efficacy of GLP-1 receptor agonists (RAs) for the prevention of stroke in patients with T2DM; and Translate current guideline recommendations for stroke prevention in patients with T2DM into practical management plans.